China Universal Asset Management Company’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $191K | Buy |
6,456
+141
| +2% | +$4.17K | 0.02% | 315 |
|
|
2025
Q1 | $189K | Sell |
6,315
-523
| -8% | -$15.6K | 0.02% | 318 |
|
|
2024
Q4 | $196K | Buy |
6,838
+642
| +10% | +$18.4K | 0.02% | 324 |
|
|
2024
Q3 | $239K | Buy |
6,196
+2,352
| +61% | +$90.9K | 0.03% | 284 |
|
|
2024
Q2 | $124K | Sell |
3,844
-2,276
| -37% | -$73.3K | 0.02% | 288 |
|
|
2024
Q1 | $238K | Buy |
6,120
+2,344
| +62% | +$91K | 0.03% | 272 |
|
|
2023
Q4 | $116K | Buy |
3,776
+2,877
| +320% | +$88.6K | 0.02% | 265 |
|
|
2023
Q3 | $20.1K | Buy |
899
+445
| +98% | +$9.95K | 0.01% | 297 |
|
|
2023
Q2 | $9.76K | Sell |
454
-8
| -2% | -$172 | ﹤0.01% | 320 |
|
|
2023
Q1 | $11.1K | Buy |
462
+121
| +35% | +$2.9K | ﹤0.01% | 286 |
|
|
2022
Q4 | $7.91K | Buy |
341
+21
| +7% | +$487 | ﹤0.01% | 248 |
|
|
2022
Q3 | $5K | Buy |
+320
| New | +$5K | ﹤0.01% | 269 |
|